Why ACET? Adicet Bio, Inc. Analysis, Price & AI Insights | Whystock
ACET
$8.20+0.65 (+8.61%)
Market ClosedLast close May 1
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.